PLX Stock: Protalix BioTherapeutics, Inc. Stock Price, Analysis & Insights
Get live PLX stock price $1.97, comprehensive Protalix BioTherapeutics, Inc. stock analysis, charts, news, and expert forecast. Real-time PLX stock data and investment insights.
Loading chart data...
Protalix BioTherapeutics, Inc. (PLX) Overview
Protalix BioTherapeutics, Inc. (PLX) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, PLX trades at $1.97 with a market capitalization of 158.73M . Over the past 52 weeks, PLX has traded between $1.32 and $3.19 , with the current price positioned at approximately 35% of this range . The stock currently tra...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 158.73M
- Current price: $1.97
- 52-week range: $1.32 - $3.19
- P/E ratio: 10.37
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Established in 1993 and based in Hackensack, New Jersey, Protalix BioTherapeutics, Inc. is a biopharmaceutical company primarily focused on advancing and globally commercializing recombinant therapeutic proteins. The firm utilizes its proprietary Pro...
Company Information
- CEO
- Dror Bashan
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 213
Contact Information
- Website
- https://www.protalix.com
- Address
- 2 University Plaza
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 10.4)
✓ Lower volatility stock (Beta: 0.01) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Protalix BioTherapeutics, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Protalix BioTherapeutics, Inc.
- ⚠Investors should consider how Protalix BioTherapeutics, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
158.73M
P/E Ratio (TTM)
10.37
Beta
0.01
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare PLX with peer companies:
- Price
- $2.35
- Market cap
- 213.61M
- Price
- $1.36
- Market cap
- 166.48M
- Price
- $8.95
- Market cap
- 445.68M
- Price
- $0.90
- Market cap
- 119.58M
- Price
- $13.86
- Market cap
- 150.55M
- Price
- $4.55
- Market cap
- 90.98M
- Price
- $2.38
- Market cap
- 283.44M
- Price
- $0.15
- Market cap
- 61.73M
- Price
- $7.15
- Market cap
- 1.02B
- Price
- $3.78
- Market cap
- 145.87M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.